Pure ovarian dysgerminoma in a postmenopausal patient: A case report and review of the management

Jennifer Vaz; Alexandra Mulliken; Nivin Omar; Jessa Suhner; Bogna Brzezinska; Thomas Cotter; Patel Nikhil; Robert V. Higgins; Bunja Rungruang

doi:10.1016/j.gore.2022.101068

Pure ovarian dysgerminoma in a postmenopausal patient: A case report and review of the management

Jennifer Vaz
, Alexandra Mulliken
, Nivin Omar
, Jessa Suhner
, Bogna Brzezinska
, Thomas Cotter
, Patel Nikhil
, Robert V. Higgins
, Bunja Rungruang

Research output: Contribution to journal › Article › peer-review

Abstract

Background: A pure ovarian dysgerminoma in a postmenopausal female is a rare phenomenon. Case: A 65-year-old female presented with a large pelvic mass. Following surgical debulking, the patient was diagnosed with FIGO Stage IIB ovarian dysgerminoma. She was treated with three cycles of etoposide and cisplatin and has been disease-free for 12 months. Conclusion: Dysgerminomas in postmenopausal females are uncommon. Gynecologic oncologists should be familiar with the pathological diagnosis and treatment recommendations to achieve optimal outcomes.

Original language	English (US)
Article number	101068
Journal	Gynecologic Oncology Reports
Volume	43
DOIs	https://doi.org/10.1016/j.gore.2022.101068
State	Published - Oct 2022

Keywords

Germ cell tumor
Ovarian germ cell tumor
Pure ovarian dysgerminoma

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/j.gore.2022.101068

Cite this

@article{9a458b781ab84a30908395981640f7ed,

title = "Pure ovarian dysgerminoma in a postmenopausal patient: A case report and review of the management",

abstract = "Background: A pure ovarian dysgerminoma in a postmenopausal female is a rare phenomenon. Case: A 65-year-old female presented with a large pelvic mass. Following surgical debulking, the patient was diagnosed with FIGO Stage IIB ovarian dysgerminoma. She was treated with three cycles of etoposide and cisplatin and has been disease-free for 12 months. Conclusion: Dysgerminomas in postmenopausal females are uncommon. Gynecologic oncologists should be familiar with the pathological diagnosis and treatment recommendations to achieve optimal outcomes.",

keywords = "Germ cell tumor, Ovarian germ cell tumor, Pure ovarian dysgerminoma",

author = "Jennifer Vaz and Alexandra Mulliken and Nivin Omar and Jessa Suhner and Bogna Brzezinska and Thomas Cotter and Patel Nikhil and Higgins, \{Robert V.\} and Bunja Rungruang",

note = "Publisher Copyright: {\textcopyright} 2022 The Authors",

year = "2022",

month = oct,

doi = "10.1016/j.gore.2022.101068",

language = "English (US)",

volume = "43",

journal = "Gynecologic Oncology Reports",

issn = "2352-5789",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Pure ovarian dysgerminoma in a postmenopausal patient

T2 - A case report and review of the management

AU - Vaz, Jennifer

AU - Mulliken, Alexandra

AU - Omar, Nivin

AU - Suhner, Jessa

AU - Brzezinska, Bogna

AU - Cotter, Thomas

AU - Nikhil, Patel

AU - Higgins, Robert V.

AU - Rungruang, Bunja

PY - 2022/10

Y1 - 2022/10

N2 - Background: A pure ovarian dysgerminoma in a postmenopausal female is a rare phenomenon. Case: A 65-year-old female presented with a large pelvic mass. Following surgical debulking, the patient was diagnosed with FIGO Stage IIB ovarian dysgerminoma. She was treated with three cycles of etoposide and cisplatin and has been disease-free for 12 months. Conclusion: Dysgerminomas in postmenopausal females are uncommon. Gynecologic oncologists should be familiar with the pathological diagnosis and treatment recommendations to achieve optimal outcomes.

AB - Background: A pure ovarian dysgerminoma in a postmenopausal female is a rare phenomenon. Case: A 65-year-old female presented with a large pelvic mass. Following surgical debulking, the patient was diagnosed with FIGO Stage IIB ovarian dysgerminoma. She was treated with three cycles of etoposide and cisplatin and has been disease-free for 12 months. Conclusion: Dysgerminomas in postmenopausal females are uncommon. Gynecologic oncologists should be familiar with the pathological diagnosis and treatment recommendations to achieve optimal outcomes.

KW - Germ cell tumor

KW - Ovarian germ cell tumor

KW - Pure ovarian dysgerminoma

UR - https://www.scopus.com/pages/publications/85139257331

UR - https://www.scopus.com/pages/publications/85139257331#tab=citedBy

U2 - 10.1016/j.gore.2022.101068

DO - 10.1016/j.gore.2022.101068

M3 - Article

AN - SCOPUS:85139257331

SN - 2352-5789

VL - 43

JO - Gynecologic Oncology Reports

JF - Gynecologic Oncology Reports

M1 - 101068

ER -

Pure ovarian dysgerminoma in a postmenopausal patient: A case report and review of the management

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this